InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

BIOLIFE SOLUTIONS INC

BLFS Clue Score49
United States Fiscal year ends December CIK 0000834365
$38.61 +0.00% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $38.61 +0.42% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 13 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−4.9Net income−6.9Fiscal year 2017Revenue11.0Operating income−1.1Net income−2.5EPS, diluted−0.21Fiscal year 2018Revenue19.7 +79.1%Operating income3.7Net income−25.0EPS, diluted−1.56Fiscal year 2019Revenue27.4 +38.6%Operating income−0.2Net income−1.7EPS, diluted−0.09Fiscal year 2020Revenue48.1 +75.7%Operating income−6.2Net income2.0EPS, diluted−0.06Fiscal year 2021Revenue119.2 +147.8%Operating income−35.2Net income−8.9 −549.2%EPS, diluted−0.23Fiscal year 2022Revenue76.2 −36.0%Operating income−5.9Net income−139.8EPS, diluted−3.25Fiscal year 2023Revenue68.0 −10.8%Operating income−17.2Net income−68.0EPS, diluted−1.55Fiscal year 2024Revenue74.6 +9.7%Operating income−4.5Net income−20.2EPS, diluted−0.44Fiscal year 2025Revenue96.2 +28.9%Operating income−16.6Net income−4.6EPS, diluted−0.10
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 11.0 19.7 27.4 48.1 119.2 76.2 68.0 74.6 96.2
Growth +79.1% +38.6% +75.7% +147.8% −36.0% −10.8% +9.7% +28.9%
Operating income −4.9 −1.1 3.7 −0.2 −6.2 −35.2 −5.9 −17.2 −4.5 −16.6
Net income −6.9 −2.5 −25.0 −1.7 2.0 −8.9 −139.8 −68.0 −20.2 −4.6
Growth −549.2%
EPS, diluted n/a −0.21 −1.56 −0.09 −0.06 −0.23 −3.25 −1.55 −0.44 −0.10

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Gross margin61.2%Operating margin−9.6%Net margin−22.8%Free cash flow margin4.2%Fiscal year 2018Gross margin68.5%Operating margin18.5%Net margin−126.7%Free cash flow margin9.4%Fiscal year 2019Operating margin−0.8%Net margin−6.1%Free cash flow margin2.0%Fiscal year 2020Operating margin−13.0%Net margin4.1%Free cash flow margin9.7%Fiscal year 2021Operating margin−29.5%Net margin−7.5%Free cash flow margin−10.9%Fiscal year 2022Operating margin−7.8%Net margin−183.4%Free cash flow margin−24.8%Fiscal year 2023Gross margin60.7%Operating margin−25.3%Net margin−100.0%Free cash flow margin−27.8%Fiscal year 2024Gross margin67.1%Operating margin−6.0%Net margin−27.0%Free cash flow margin7.0%Fiscal year 2025Gross margin64.6%Operating margin−17.3%Net margin−4.8%Free cash flow margin11.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 61.2% 68.5% n/a n/a n/a n/a 60.7% 67.1% 64.6%
Operating margin n/a −9.6% 18.5% −0.8% −13.0% −29.5% −7.8% −25.3% −6.0% −17.3%
Net margin n/a −22.8% −126.7% −6.1% 4.1% −7.5% −183.4% −100.0% −27.0% −4.8%
Free cash flow margin n/a 4.2% 9.4% 2.0% 9.7% −10.9% −24.8% −27.8% 7.0% 11.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−4.3Capital expenditure−0.1Free cash flow−4.5Fiscal year 2017Operating cash flow0.6Capital expenditure−0.1Free cash flow0.5Fiscal year 2018Operating cash flow2.3Capital expenditure−0.5Free cash flow1.8 +300.9%Fiscal year 2019Operating cash flow1.2Capital expenditure−0.7Free cash flow0.5 −70.9%Fiscal year 2020Operating cash flow6.6Capital expenditure−2.0Free cash flow4.7 +770.6%Fiscal year 2021Operating cash flow−4.6Capital expenditure−8.4Free cash flow−13.0 −377.1%Fiscal year 2022Operating cash flow−8.5Capital expenditure−10.4Free cash flow−18.9Fiscal year 2023Operating cash flow−12.5Capital expenditure−6.4Free cash flow−18.9Fiscal year 2024Operating cash flow8.4Capital expenditure−3.2Free cash flow5.2Fiscal year 2025Operating cash flow20.1Capital expenditure−9.5Free cash flow10.6 +104.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −4.3 0.6 2.3 1.2 6.6 −4.6 −8.5 −12.5 8.4 20.1
Capital expenditure −0.1 −0.1 −0.5 −0.7 −2.0 −8.4 −10.4 −6.4 −3.2 −9.5
Free cash flow −4.5 0.5 1.8 0.5 4.7 −13.0 −18.9 −18.9 5.2 10.6
Growth +300.9% −70.9% +770.6% −377.1% +104.4%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash1.4Total debt4.3Net cash (debt)−2.8Shareholders’ equity3.2Debt to equity1.34Fiscal year 2017Cash6.7Shareholders’ equity−9.5Fiscal year 2018Cash30.7Shareholders’ equity14.6Fiscal year 2019Cash6.4Total debt0.0Net cash (debt)6.4Shareholders’ equity43.3Debt to equity0.00Fiscal year 2020Cash90.4Total debt1.3Net cash (debt)89.1Shareholders’ equity204.4Debt to equity0.01Fiscal year 2021Cash69.9Total debt7.2Net cash (debt)62.6Shareholders’ equity478.0Debt to equity0.02Fiscal year 2022Cash19.4Total debt25.6Net cash (debt)−6.2Shareholders’ equity364.2Debt to equity0.07Fiscal year 2023Cash27.9Total debt23.8Net cash (debt)4.1Shareholders’ equity337.7Debt to equity0.07Fiscal year 2024Cash91.5Total debt15.9Net cash (debt)75.6Shareholders’ equity348.9Debt to equity0.05Fiscal year 2025Cash33.0Total debt5.0Net cash (debt)28.0Shareholders’ equity371.9Debt to equity0.01
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 1.4 6.7 30.7 6.4 90.4 69.9 19.4 27.9 91.5 33.0
Total debt 4.3 n/a n/a 0.0 1.3 7.2 25.6 23.8 15.9 5.0
Net cash (debt) −2.8 n/a n/a 6.4 89.1 62.6 −6.2 4.1 75.6 28.0
Shareholders’ equity 3.2 −9.5 14.6 43.3 204.4 478.0 364.2 337.7 348.9 371.9
Debt to equity 1.34 n/a n/a 0.00 0.01 0.02 0.07 0.07 0.05 0.01

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018† 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 11.0 19.7 27.4 48.1 119.2 76.2 68.0 74.6 96.2
Growth +79.1% +38.6% +75.7% +147.8% −36.0% −10.8% +9.7% +28.9%
3.4 4.3 6.2 8.8 n/a n/a n/a 26.7 24.6 34.1
4.8 6.7 13.5 n/a n/a n/a n/a 41.3 50.1 62.1
Growth +41.2% +100.5% +21.2% +24.0%
2.0 1.2 1.3 3.2 6.7 11.8 8.7 5.5 4.8 7.6
4.6 4.5 6.0 8.9 15.3 33.7 33.3 42.8 40.6 45.5
−4.9 −1.1 3.7 −0.2 −6.2 −35.2 −5.9 −17.2 −4.5 −16.6
Growth −106.0%
n/a −2.5 −25.0 −3.2 −1.3 −29.0 −4.8 −12.2 −8.8 −12.1
0.0 0.0 n/a −1.5 −3.3 −20.1 −5.2 −0.1 −0.0 0.0
−6.9 −2.5 −25.0 −1.7 2.0 −8.9 −139.8 −68.0 −20.2 −4.6
Growth −549.2%
Per share
n/a −0.21 −1.56 −0.09 0.07 −0.23 −3.29 −1.55 −0.44 −0.09
n/a −0.21 −1.56 −0.09 −0.06 −0.23 −3.25 −1.55 −0.44 −0.10
Growth
n/a 13.3 16.3 19.5 27.3 38.5 42.5 43.7 46.1 47.8
n/a 13.3 21.6 n/a n/a 38.5 43.1 43.7 46.1 48.6
Growth +63.1% +11.9% +1.5% +5.4% +5.6%

† The diluted share count jumps at 2018 and 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 14.9% a year over five years.
  • Operating margin is down 4.3 points on five years ago, at -17.3%.
  • A net loss in 9 of 10 years on file.